Preventing and Responding to Hypoglycemia in Older People with Diabetes in Viet Nam: Individualized Risk, Medication–Meal Coordination and Timely Clinical Escalation

Preventing and Responding to Hypoglycemia in Older People with Diabetes in Viet Nam: Individualized Risk, Medication–Meal Coordination and Timely Clinical Escalation

INTEGRATED CARE & CARE TRANSITIONS | AGE-FRIENDLY CARE QUALITY

Last reviewed: November 4, 2026

An older man with diabetes lives in a residential care facility. His medications have been prescribed by a healthcare professional, and staff help him with meals and his daily routine. One morning, he eats very little breakfast because he feels unwell. The employee assisting him notices the change, but the information does not reach the person responsible for coordinating his medication support.

Later that morning, he becomes unusually quiet, weak, and confused. At first, staff wonder whether he is simply tired or experiencing symptoms related to an existing cognitive condition. It is only when his condition is assessed further that hypoglycemia becomes a concern.

Nothing in this situation necessarily means that his medication was prescribed incorrectly or that someone deliberately overlooked a warning. The problem may lie in the connection between different parts of his care. His treatment plan, actual food intake, clinical monitoring, and everyday support were not sufficiently coordinated.

Similar situations can arise at home, in outpatient services, and during transitions between hospital and long-term care. An older person may eat less during an illness, miss a meal, experience difficulty managing medications, or continue following a treatment routine that no longer matches their health and functional abilities.

Hypoglycemia, or low blood glucose, can have serious consequences. Severe episodes may cause loss of consciousness, seizures, falls, injuries, or other medical emergencies. Less severe episodes can also interfere with daily activities, reduce confidence, and create anxiety about future events.

Yet older people with diabetes do not all face the same risks. The likelihood of hypoglycemia depends on the medications they receive, their health conditions, eating patterns, previous episodes, and ability to recognize and respond to changes in glucose levels.

For healthcare providers, home-care services, and residential long-term care organizations in Viet Nam, prevention is therefore not simply a matter of reminding people to eat regularly or take their medications correctly. It requires clinical treatment plans that reflect individual circumstances, dependable communication between caregivers and healthcare professionals, and a clear response when something changes.

Understanding Hypoglycemia and Why It Matters

Hypoglycemia occurs when blood glucose falls below an important clinical threshold. In people with diabetes, it is commonly associated with glucose-lowering treatment, particularly insulin and medications that stimulate insulin secretion.

The American Diabetes Association (ADA), in Section 6 of its Standards of Care in Diabetes—2026, identifies three levels of hypoglycemia.

Level 1 hypoglycemia refers to glucose below 70 mg/dL (3.9 mmol/L) but at or above 54 mg/dL (3.0 mmol/L). This is an important alert level, even when a person does not experience recognizable symptoms.

Level 2 hypoglycemia refers to glucose below 54 mg/dL (3.0 mmol/L). It represents clinically significant hypoglycemia requiring prompt action.

Level 3, or severe hypoglycemia, is defined by altered mental or physical functioning that requires assistance from another person for treatment, regardless of the measured glucose concentration.

These distinctions are important because the severity of an episode cannot always be judged by symptoms alone. Someone may have a clinically significant glucose reduction without obvious warning signs. Another person may become confused or unable to manage their own treatment before a glucose measurement can be obtained.

Common symptoms include sweating, trembling, hunger, palpitations, dizziness, weakness, irritability, and confusion. However, the presentation may be less recognizable in older people. Sudden withdrawal, unusual sleepiness, difficulty concentrating, or a change in behavior may be more apparent than the symptoms traditionally associated with low glucose.

Some individuals also develop impaired awareness of hypoglycemia, meaning that they no longer recognize the warning symptoms reliably. This can make episodes particularly dangerous when the person lives alone or depends on others for assistance.

The effects may continue beyond the immediate event. Hypoglycemia can interfere with mobility, independence, and confidence in managing diabetes. Recurrent episodes may lead people to avoid activities or become anxious about taking prescribed medications.

At the same time, symptoms such as weakness, confusion, or altered consciousness can have other serious causes. Hypoglycemia should be considered when relevant, but it should not become an automatic explanation for every sudden change in an older person's condition.

The clinical classifications provide a foundation for recognizing risk and guiding treatment. They do not, by themselves, authorize employees without appropriate clinical responsibilities to diagnose hypoglycemia, change prescriptions, or undertake regulated medical procedures.

Individual Risk Matters More Than Age Alone

Older adults with diabetes are a diverse population. Some remain physically active, manage complicated treatment regimens independently, and recognize changes in their glucose levels. Others live with frailty, cognitive impairment, kidney disease, or multiple chronic conditions that make diabetes management more difficult.

The ADA's 2026 guidance emphasizes identifying and addressing hypoglycemia during routine clinical care, particularly among people receiving treatments associated with an increased risk of low glucose.

Previous hypoglycemic episodes are especially important. A person who has recently experienced clinically significant or severe hypoglycemia may be more likely to experience another episode, particularly if the underlying circumstances remain unchanged.

Kidney impairment can also increase vulnerability by affecting glucose regulation and the handling of certain medications. Cognitive difficulties may interfere with remembering doses, interpreting glucose readings, recognizing symptoms, or obtaining assistance.

Eating patterns deserve equal attention. An older person with a predictable routine may manage well until illness, poor appetite, swallowing difficulties, or dependence on meal assistance disrupts that routine.

The availability of support can make a substantial difference. Someone who lives with family members may receive help when symptoms appear. A person living alone may have no immediate assistance. In residential care, support may be available throughout the day, but its effectiveness still depends on communication, staff competence, and access to appropriate clinical services.

Financial and practical circumstances matter as well. Difficulty obtaining suitable food, prescribed medications, glucose-monitoring supplies, or follow-up care can affect the safety of diabetes management.

An individualized assessment should consider more than a person's diagnosis and medication list. It should examine how diabetes is actually managed throughout the day, what the person can do independently, where assistance is needed, and what happens when their usual routine is interrupted.

Age may influence risk, but it does not replace an assessment of the individual.

Understanding Medication-Related Hypoglycemia Risk

Not all diabetes medications carry the same risk of hypoglycemia.

Insulin, sulfonylureas, and meglitinides are particularly associated with low glucose. Other commonly used treatments for type 2 diabetes generally have a lower intrinsic risk when used without insulin or insulin secretagogues.

However, a medication's usual risk profile does not determine the safety of an entire treatment regimen. Drug combinations, changes in kidney function, acute illness, reduced food intake, and previous hypoglycemic episodes may alter the overall risk.

For older people with complex health needs, the balance between treatment benefits and potential harms deserves regular clinical review.

The ADA's 2026 recommendations support selecting medications with lower hypoglycemia risk when appropriate and considering treatment simplification or deintensification when the burdens or harms of treatment outweigh its expected benefits.

These decisions depend on the type of diabetes, the individual's clinical condition, treatment history, glucose patterns, functional abilities, preferences, and therapeutic goals. They belong to appropriately qualified healthcare professionals.

An important distinction concerns the management of insulin when food intake changes.

If an older person receiving insulin suddenly eats much less than usual, the situation may require prompt clinical advice. It does not mean that a family member or care worker should automatically stop insulin.

For people with type 1 diabetes, continued insulin treatment is essential. Inappropriate interruption, particularly of basal insulin, can lead to diabetic ketoacidosis, a potentially life-threatening complication.

Other glucose-lowering medications may also require specific instructions during illness or missed meals. These instructions should come from the treating clinician and take account of the actual medication and clinical circumstances.

Some people manage their medications independently and have been taught how to follow an individualized treatment plan when eating patterns change. Others depend on authorized healthcare personnel or caregivers for aspects of medication support.

Care organizations need to recognize these differences rather than apply one general rule to everyone with diabetes.

Medication safety is not demonstrated simply by confirming that the prescribed dose was taken. It also depends on whether the treatment remains appropriate to the person's current circumstances and whether important changes reach the responsible healthcare professional.

Connecting Medication Timing With Actual Food Intake

Food intake is one of the most practical yet easily overlooked aspects of hypoglycemia prevention.

A medication regimen may have been prescribed on the assumption that a person will eat at reasonably predictable times and consume an expected amount of food. When those assumptions no longer reflect daily life, the treatment may need reassessment.

Consider an older resident who usually eats breakfast at 7:30 a.m. One morning, meal assistance is delayed. On another day, breakfast arrives on time, but the resident eats only a few spoonfuls because of nausea. The meal may have been served in both situations, yet the person's actual intake is very different.

For someone receiving certain insulin regimens or medications that stimulate insulin secretion, that difference can be clinically important.

The ADA's 2026 guidance recognizes the challenges of unpredictable food consumption in post-acute and long-term care settings. In selected circumstances, clinicians may prescribe a mealtime insulin approach that reflects the amount of carbohydrate actually consumed.

For example, immediate post-meal administration of appropriately prescribed rapid-acting insulin may be useful in some long-term care situations. However, this approach has specific clinical considerations and is not suitable for every insulin formulation or treatment regimen.

It should not be interpreted as a recommendation to give all insulin after meals or to allow care workers to change administration times independently.

Likewise, not all diabetes medications must be taken with food, and missing a meal does not automatically justify withholding medication.

The practical issue for a care organization is whether the person responsible for treatment has reliable information about what the individual actually ate.

An employee who assists with meals may observe that a resident has barely touched their food. A family caregiver may notice that an older parent has been skipping lunch. A home-care worker may discover that the person has difficulty preparing meals safely.

These observations can be valuable when they are communicated through an appropriate care arrangement.

A meal-service record showing that lunch was delivered does not establish that the person consumed the amount anticipated in the clinical plan. Similarly, a medication record showing that treatment was given does not establish whether the associated nutritional circumstances were suitable.

Meal assistance, nutrition support, medication management, and clinical monitoring are different activities, but they should not operate in isolation.

The objective is not to make every employee responsible for managing diabetes. It is to ensure that relevant changes in eating patterns are recognized and reach the people qualified and authorized to respond.

When Appetite Changes or Illness Disrupts the Routine

Reduced appetite is common among older people, but its significance depends on the circumstances.

Someone may occasionally dislike a particular meal without experiencing a medical problem. Another person may have persistent nausea, swallowing difficulties, dehydration, an acute infection, or a gradual deterioration in nutritional status.

These situations require different responses.

For a person receiving treatment associated with hypoglycemia, reduced intake may also increase medication-related risk. The concern becomes greater when the person cannot describe symptoms, has recently experienced hypoglycemia, or is unable to obtain help independently.

Acute illness deserves particular attention. Fever, vomiting, diarrhea, changes in hydration, and altered food intake can affect glucose levels and medication requirements. Illness does not always cause low glucose; it may also contribute to hyperglycemia and other metabolic complications.

This is why individualized illness-management instructions are important for people receiving insulin or other treatments that may require adjustment during periods of reduced intake.

The responsible healthcare professional may establish a plan covering glucose monitoring, medication-related actions, hydration, nutrition, and circumstances requiring urgent assessment.

Caregivers should understand the parts of that plan relevant to their role.

A person who needs to fast before a medical procedure presents another example. The clinical team should determine how fasting, glucose monitoring, and medication management will be coordinated. Simply telling someone not to eat, without considering their diabetes treatment, may create avoidable risk.

In residential care, changes in appetite should be considered alongside the person's preferences and ability to eat comfortably. Food texture, swallowing safety, meal assistance, cultural preferences, and the dining environment may all influence intake.

Sometimes a suitable alternative meal or improved assistance can resolve a practical problem. In other circumstances, nutritional or clinical assessment is necessary.

A general instruction to encourage eating is not an adequate substitute for a clinical plan when medication-related hypoglycemia is a significant concern.

Recognizing When Something Is Wrong

Hypoglycemia can be difficult to recognize in older people, particularly when symptoms do not follow a familiar pattern.

An older woman who usually enjoys talking with other residents may suddenly become withdrawn and unable to follow a conversation. A man who normally walks independently may appear unusually unsteady. Someone with dementia may become more confused than usual, while another person may simply seem less responsive.

These changes should not automatically be attributed to aging or an established cognitive diagnosis.

The ADA's 2026 recommendations emphasize vigilance for hypoglycemia when cognitive function is impaired or declining. Regular assessment of cognition and awareness of previous hypoglycemic episodes can help clinicians and caregivers identify people who may need additional support.

Knowing the person's usual condition is particularly valuable.

Family members and regular caregivers may recognize subtle changes that are difficult for unfamiliar staff to interpret. A comment such as "He is not behaving like himself today" can provide important information, especially when the change is sudden.

Nevertheless, recognizing a possible problem is different from making a diagnosis.

Stroke, delirium, infection, adverse medication effects, and other medical conditions can also cause weakness, confusion, or altered consciousness. Some require immediate treatment.

Where hypoglycemia is suspected, glucose should be assessed promptly when appropriate and feasible within the individual's clinical or authorized care arrangements. Necessary emergency assistance should not be delayed while attempting to obtain a measurement.

A normal or reassuring glucose result should not be used to dismiss serious symptoms that persist.

The safest approach is to recognize a significant change, consider the relevant risks, and obtain appropriate professional assistance without making unsupported assumptions.

Responding to Suspected and Severe Hypoglycemia

The response to suspected hypoglycemia depends on the person's condition and ability to participate safely in treatment.

For someone who is conscious, alert, and able to swallow safely, prompt treatment with fast-acting glucose or an appropriate glucose-containing carbohydrate is an established approach when hypoglycemia is present.

The ADA's 2026 standards identify glucose as the preferred initial treatment for a conscious person with glucose below 70 mg/dL (3.9 mmol/L), while recognizing that other glucose-containing carbohydrates may be used. The guidance also emphasizes reassessment after initial treatment and additional action if hypoglycemia persists.

People with diabetes and those expected to assist them should receive education appropriate to the individual's treatment plan. Staff and family caregivers should know which previously agreed actions they can take and when professional help is required.

Necessary and appropriate first aid should not be delayed solely because a healthcare professional has not yet been contacted.

However, a very different response is required when a person is unconscious, experiencing a seizure, unable to cooperate sufficiently for safe oral treatment, or unable to swallow safely.

Food and drink must not be given by mouth in these circumstances because of the risk of choking or aspiration.

Emergency medical assistance should be requested without delay. In Viet Nam, the medical emergency number is 115. The person should receive appropriate first aid within the capabilities and training of those present while emergency assistance is being arranged.

For people at risk of severe hypoglycemia, the ADA recommends access to prescribed glucagon and education for family members, caregivers, and others expected to provide assistance.

Glucagon may be an important emergency rescue treatment, but its availability and use depend on the product, the person's clinical plan, and applicable professional and legal requirements.

An international clinical recommendation does not automatically authorize every non-clinical employee in Viet Nam to prepare or administer emergency medication.

Where glucagon has been prescribed, the care organization and responsible clinicians should clarify in advance who may assist, what training and authorization are required, where the medication is kept, and what arrangements apply if the designated person is unavailable.

The possibility of recurrent hypoglycemia also matters. Symptoms may improve after initial treatment, but glucose can fall again, particularly when certain medications remain active.

Clinical reassessment and further monitoring may therefore be necessary even when the person appears to have recovered.

The guiding principle is to act promptly within appropriate first-aid and professional arrangements, obtain emergency assistance when indicated, and avoid delaying care because responsibilities have not been clarified beforehand.

Making Individualized Care Plans Work in Everyday Practice

A resident's medical record may contain a diabetes diagnosis, a medication list, and recent glucose results. That information alone may not be enough for employees to understand what they are expected to do when the person becomes unwell.

An effective care arrangement connects clinical instructions with the realities of daily support.

The responsible healthcare professional should establish and review the individual's diabetes treatment plan, including relevant hypoglycemia risks, glucose-monitoring requirements, medication instructions, and actions appropriate to different clinical situations.

For someone at significant risk, the plan may also address illness, missed meals, reduced appetite, fasting, impaired symptom awareness, and emergency escalation.

The organization then needs to establish how its staff will support the plan within their actual responsibilities.

A home-care worker may be expected to notice changes in appetite and notify an authorized contact. A residential care employee may help document food intake and report unusual behavior. Licensed healthcare professionals may undertake glucose assessment, treatment, and medication-related decisions according to their authorized scope of practice.

These roles are not interchangeable.

Particular attention is needed when an older person uses insulin independently but begins experiencing visual, cognitive, or physical difficulties. The person may still be able to perform some tasks while needing assistance with others.

Care planning should reflect these abilities rather than assume that everyone with diabetes is either fully independent or entirely dependent.

An individualized plan must also remain usable when the normal routine breaks down. A meal may be delayed, an employee may be absent, a glucose monitor may malfunction, or symptoms may develop when the usual clinician is unavailable.

The person receiving care and, where appropriate, authorized family members should understand whom to contact and how assistance can be obtained.

Written instructions become meaningful only when the people expected to follow them have access to the relevant information, understand their responsibilities, and can act safely when circumstances change.

If a care organization cannot meet an individual's needs within its lawful services and available capabilities, additional professional support or alternative healthcare arrangements may be necessary.

Glucose Monitoring and the Role of Technology

Blood glucose meters and continuous glucose monitoring (CGM) systems can support the detection and management of hypoglycemia.

The ADA's Standards of Care in Diabetes—2026 recommends CGM for older adults with type 1 diabetes and older adults with type 2 diabetes receiving insulin, with evidence grades A and B, respectively.

CGM may also benefit other individuals at increased risk of hypoglycemia when clinically appropriate.

For some older people, continuous monitoring can reveal glucose reductions that would otherwise go unnoticed, including episodes during sleep. Alerts and glucose trends may help individuals and their healthcare teams respond earlier.

However, a monitoring device does not provide safe care on its own.

An older person may be unable to understand an alarm, respond to changing glucose values, or manage the device independently. A family caregiver may be unfamiliar with the technology. Residential staff may receive an alert without knowing what action has been authorized.

These practical issues need to be considered before introducing monitoring technology.

CGM systems generally measure glucose in interstitial fluid rather than directly in blood. Readings may differ from blood glucose measurements, particularly when glucose levels change rapidly. Depending on the device and clinical circumstances, confirmation with an appropriate blood glucose measurement may be needed when readings do not match symptoms or other information.

A sensor alert can indicate that attention is required. It does not independently determine the correct medication adjustment or establish that a particular treatment should be given.

Nor should digital monitoring replace direct assessment when a person appears seriously unwell.

For organizations using connected devices, responsibility for responding to alerts should be clear. A monitoring system that generates information but has no reliable response arrangement may create false reassurance.

Technology selection should take account of the individual's clinical needs, preferences, abilities, caregiver support, affordability, device requirements, and the organization's practical capacity.

HLVN does not recommend universal CGM adoption or endorse a particular commercial system for every older person with diabetes.

The objective is reliable recognition and response, supported by appropriate technology where it adds value.

Preventing Problems During Transitions Between Care Settings

Transitions between hospital, home, outpatient services, and residential long-term care can create particular risks for people with diabetes.

Medication requirements may change during hospitalization because of acute illness, procedures, nutritional intake, or altered kidney function. When the person leaves hospital, their usual routine may resume, but their treatment plan may no longer be the same.

Difficulties arise when information about these changes is incomplete, delayed, or misunderstood.

A family may continue following medication instructions issued before admission. A residential care facility may receive a discharge summary without clear information about the current insulin regimen. A home-care provider may not know that the person recently experienced severe hypoglycemia.

These gaps can compromise safe care even when each individual provider has acted appropriately within their own setting.

Discharge communication should make relevant medication changes, monitoring requirements, known hypoglycemia risks, and follow-up responsibilities sufficiently clear to the receiving healthcare team and those supporting everyday care.

Information about eating difficulties, swallowing problems, cognitive changes, or new dependence on assistance may also be important.

The older person should receive an understandable explanation of changes to their treatment and know whom to contact when questions arise.

Where the receiving organization identifies conflicting or incomplete clinical instructions, its employees should not resolve the discrepancy by independently selecting or modifying prescriptions.

Clarification should be obtained from an appropriately qualified healthcare professional.

The same principle applies to family caregivers. They should not be left to decide which of several inconsistent treatment instructions is clinically correct.

A safe transition is more than the transfer of medical documents. It requires a shared understanding of the current care plan, the assistance that will be provided, and the professional responsibilities that remain with the treating healthcare team.

Balancing Glucose Control, Safety, and Quality of Life

Good diabetes care in older age is not defined by achieving the lowest possible glucose level or the same glycemic target for every individual.

People have different health conditions, treatment burdens, priorities, and abilities to manage their diabetes.

A relatively healthy older adult may benefit from one set of treatment goals, while someone with frailty, advanced cognitive impairment, significant comorbidities, or limited life expectancy may need a different approach.

The ADA's 2026 guidance emphasizes individualized glycemic goals and careful consideration of treatment-related risks.

For some people, avoiding hypoglycemia and reducing the burden of a complex treatment regimen may be particularly important. Others may be able to maintain more specific glucose goals safely.

Less intensive treatment should not be confused with neglecting diabetes care. Significant hyperglycemia can also cause symptoms, dehydration, acute illness, and other complications.

The appropriate balance requires clinical judgment and discussion with the person receiving care.

Everyday preferences are relevant to these discussions.

An older resident may wish to enjoy familiar Vietnamese meals, participate in family celebrations, or maintain an independent daily routine. Another person may find frequent glucose checks distressing or struggle with the timing of meals and medications.

These preferences do not eliminate clinical risks, but they can help healthcare professionals develop treatment plans that are realistic and acceptable.

When a resident repeatedly cannot eat at the times expected by a prescribed regimen, the response should not simply be to insist on a rigid routine.

The clinical plan, nutrition arrangements, and practical support may need to be reviewed together.

Person-centered diabetes care aims to protect health while preserving dignity, independence, and quality of life wherever possible.

Learning From Hypoglycemic Episodes

An episode of hypoglycemia should not be considered resolved from a quality and safety perspective merely because the immediate symptoms have improved.

Clinically significant events may indicate a need to review medications, glucose-monitoring arrangements, nutritional intake, or the individual's overall treatment goals.

Recommendation 6.19 of the ADA's Standards of Care in Diabetes—2026 states that one or more level 2 or level 3 hypoglycemic episodes should prompt reevaluation of the treatment plan, including consideration of medication changes when appropriate.

That reassessment is a clinical responsibility.

From an organizational perspective, the same event may reveal weaknesses in everyday care coordination.

For example, a resident may have eaten very little before receiving medication support. A change in appetite may have been observed but not communicated. A discharge medication change may not have reached the relevant team. Staff may have recognized concerning symptoms but been uncertain about whom to contact.

Understanding these circumstances can help an organization identify practical improvements.

Not every episode is preventable. Hypoglycemia can occur despite appropriate prescribing, careful monitoring, and reliable support.

Nevertheless, repeated events should not automatically be accepted as an unavoidable consequence of diabetes or old age.

A residential facility may discover that several episodes occurred after delays in meal assistance. A home-care service may find that a client repeatedly struggles with medication instructions following hospital discharge. An outpatient team may identify recurring hypoglycemia associated with an increasingly complicated treatment regimen.

Each situation calls for an appropriate response involving the people responsible for clinical treatment and those coordinating everyday care.

Quality measurement can support this learning, provided indicators are interpreted carefully.

The recorded number of hypoglycemic episodes is important, but it does not tell the whole story. A low reported rate may reflect effective prevention, or it may reflect missed symptoms and incomplete documentation.

A higher rate may indicate greater clinical risk, better detection, or changes in the population receiving care.

Organizations should therefore examine both clinical outcomes and the reliability of relevant care processes.

For licensed healthcare providers, this may include appropriate review of hypoglycemia occurrence, severity, recurrence, treatment, and follow-up.

For residential and home-based care organizations, useful questions include whether significant changes in food intake are communicated, whether current care instructions are available, and whether concerning symptoms lead to timely assistance.

Feedback from older people, families, and staff can provide additional insight.

Someone may be afraid of another episode and avoid leaving home. A caregiver may struggle to understand a changing medication regimen. An employee may repeatedly encounter uncertainty about what to do when a resident misses a meal.

These experiences can reveal problems that clinical records alone may not show.

Measures should not encourage unnecessary glucose testing, restrictive meal practices, or uniform glucose targets that disregard individual circumstances.

The purpose of quality improvement is to identify preventable weaknesses, strengthen communication, and ensure that clinically important changes receive appropriate attention.

Understanding Viet Nam's Legal and Professional Framework

Preventing and responding to hypoglycemia requires a clear distinction between everyday care support and regulated clinical activities.

Viet Nam's Law on Medical Examination and Treatment No. 15/2023/QH15, effective January 1, 2024, as amended, provides the principal legal framework governing medical examination and treatment.

Consolidated Document No. 26/VBHN-VPQH, issued by the Office of the National Assembly on February 26, 2026, provides an official consolidated reference to the law and its amendments. It should be understood as a consolidated legal text rather than a separate new law.

These legal provisions are relevant to professional practice, patient rights, healthcare establishments, and the conditions under which regulated healthcare services may be provided.

Clinical assessment, diagnosis, prescribing, medication changes, and treatment decisions concerning significant medical deterioration must take place within appropriate professional and organizational arrangements.

However, the existence of regulated clinical responsibilities does not mean that every activity related to diabetes is restricted to licensed healthcare practitioners.

People with diabetes may lawfully undertake self-monitoring and follow individualized treatment instructions provided by their healthcare professionals. Family members and other caregivers may also provide appropriate support, depending on the activity, their competence, the individual's circumstances, and applicable legal requirements.

The important question is what a particular person is authorized and competent to do in a particular setting.

A residential social care provider should not assume that employees may independently prescribe, modify insulin regimens, interpret clinical findings for treatment decisions, or perform regulated medical procedures simply because they assist residents with daily activities.

Where an organization operates licensed healthcare services, the applicable professional and establishment requirements must be met.

Viet Nam also has national clinical guidance relevant to diabetes management.

The Ministry of Health issued Decision No. 5481/QD-BYT on December 30, 2020, promulgating the Guidelines for Diagnosis and Treatment of Type 2 Diabetes.

Decision No. 1353/QD-BYT, issued on February 23, 2021, subsequently amended and supplemented certain provisions of those guidelines.

These documents remain relevant domestic professional references, subject to applicable updates and current clinical requirements. They should not be treated as a single operational protocol covering every medication, emergency situation, or type of care organization.

Another relevant development is Ministry of Health Decision No. 1976/QD-BYT, issued on July 1, 2026, promulgating Professional Guidance on Care for Older Persons at Home and in the Community.

This guidance addresses the organization and delivery of care for older people within its defined scope, including aspects of daily living, nutrition, health-related knowledge, and community-based support.

It provides useful domestic context for developing safer home-care and community-care arrangements. However, it does not replace specialized diabetes clinical guidelines or independently authorize non-clinical caregivers to make medical treatment decisions.

The Law on Older Persons No. 39/2009/QH12, as amended, also forms part of the broader legal context for respecting the rights, interests, and care needs of older people in Viet Nam.

For HLVN, the practical distinction is between helping an older person follow an established clinical plan safely and undertaking activities that require specific professional authority.

Organizations should determine their responsibilities according to their legal status, permitted services, workforce competence, and applicable Vietnamese requirements, rather than assuming that international care practices can be adopted without local consideration.

Protecting Personal Health Information

Preventing hypoglycemia often requires information to be shared between healthcare professionals, residents, family caregivers, and staff involved in everyday care.

Relevant information may include prescribed medication instructions, glucose-monitoring records, changes in food intake, previous hypoglycemic episodes, and emergency-care arrangements.

This information needs to be accessible to people with a legitimate role in providing care, but access must be governed by appropriate legal and organizational arrangements.

Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and Government Decree No. 356/2025/ND-CP both took effect on January 1, 2026.

Their requirements must be considered alongside the confidentiality and patient-rights provisions of the Law on Medical Examination and Treatment and other applicable legislation.

Healthcare and care organizations should establish who may access relevant information, how it is recorded and communicated, and what safeguards are needed to prevent inappropriate disclosure.

Connected glucose-monitoring devices, mobile applications, and cloud-based platforms introduce additional considerations involving access permissions, data security, external service providers, and potentially cross-border data processing.

The fact that a family member assists with meals or medications does not automatically establish unrestricted access to all of the older person's medical information.

Information sharing should reflect the person's rights, lawful choices, relevant authorizations, and the requirements necessary for safe care.

The objective is to provide the information needed for appropriate support without unnecessary collection or disclosure of personal health data.

Learning From International Guidance and Care Quality Standards

International guidance offers valuable insights into diabetes care for older people, although recommendations must be interpreted according to their intended purpose and the circumstances in which they will be applied.

The ADA's Standards of Care in Diabetes—2026 provides clinical recommendations concerning hypoglycemia assessment, prevention, treatment, glucose monitoring, medication selection, and individualized diabetes management.

Section 13 addresses older adults, including those receiving post-acute and long-term care.

Recommendation 13.16 supports diabetes education and training for staff in these settings, including relevant training concerning continuous glucose monitoring, insulin pumps, and advanced insulin delivery systems.

Recommendation 13.17 emphasizes careful assessment of mobility, cognitive functioning, medications, management preferences, and clinical and functional status when establishing individualized glycemic goals and selecting appropriate treatments or devices.

Both recommendations carry an evidence grade of E within the ADA's classification system, reflecting expert consensus or clinical experience rather than evidence from high-certainty randomized trials.

Their practical significance is the recognition that diabetes care in long-term care settings depends not only on clinical prescribing but also on workforce preparation and the way services are organized.

The ADA's 2016 position statement, Management of Diabetes in Long-term Care and Skilled Nursing Facilities, remains a useful background reference concerning individualized treatment, nutrition, medication management, staff education, and hypoglycemia prevention. Its recommendations should be interpreted alongside newer clinical guidance.

In August 2026, the ADA published A Practical Guide to Hypoglycemia: New Approaches to Overcoming a Persistent Barrier to Optimal Glycemic Management.

Its chapter on prevention and risk mitigation discusses medication-related strategies, technology, education, caregiver involvement, and broader organizational approaches.

This publication offers additional professional perspectives, but its authors' opinions should be distinguished from the ADA's formal Standards of Care. The publication explicitly states that its content does not represent official ADA policy.

Beyond diabetes-specific guidance, ISO 25557:2026, Ageing Societies — Care Quality for Older Persons at Home and in Care Facilities, provides an international reference concerning the quality of health and social care services for older people.

The standard addresses person-centered care, safety, workforce competence, organizational responsibilities, and the coordination of services according to individual needs and preferences.

It is relevant to care quality and organizational arrangements, but it does not establish clinical diabetes treatment guidelines, insulin doses, glucose targets, or emergency medication protocols.

These different sources should be understood as complementary rather than interchangeable.

Clinical diabetes guidance informs professional assessment and treatment. Broader care quality standards support the organization of safe, coordinated, and person-centered services. Vietnamese legislation and professional requirements determine the lawful framework within which services operate.

For organizations seeking to improve hypoglycemia prevention, the most useful approach is to bring these perspectives together without confusing recommendations, standards, and legal obligations.

Reliable Care Connects Clinical Treatment With Everyday Life

Hypoglycemia prevention is closely connected to the ordinary routines of daily living.

A treatment plan may be clinically appropriate when prescribed, yet become difficult to follow safely when a person's appetite changes, cognition declines, mobility becomes limited, or dependable assistance is no longer available.

The employee helping with breakfast may notice that a resident has eaten very little. A family caregiver may recognize an unusual change in behavior. A healthcare professional may identify medication-related risks that require reassessment.

Each person sees a different part of the situation.

The opportunity for healthcare and long-term care organizations is to ensure that relevant information reaches the people who are qualified and authorized to act on it.

This does not require turning every caregiver into a diabetes specialist or assuming that every episode of hypoglycemia can be prevented.

It requires recognizing individual vulnerability, maintaining reliable communication, supporting appropriate clinical decisions, and responding promptly when concerning changes occur.

For older people with diabetes, safe care is not demonstrated simply by whether medications have been administered or glucose readings have been documented.

It is demonstrated through the continuing connection between clinical treatment, actual food intake, individual abilities and preferences, and timely access to appropriate healthcare support.

When those elements work together, diabetes care is better positioned to protect both safety and quality of life.

Key References and Regulatory Context

American Diabetes Association Professional Practice Committee for Diabetes. (2026). 13. Older Adults: Standards of Care in Diabetes—2026. Diabetes Care, 49(Supplement 1), S277–S296. DOI: 10.2337/dc26-S013.

American Diabetes Association Professional Practice Committee for Diabetes. (2026). 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026. Diabetes Care, 49(Supplement 1), S132–S149. DOI: 10.2337/dc26-S006.

American Diabetes Association. (2026). A Practical Guide to Hypoglycemia: New Approaches to Overcoming a Persistent Barrier to Optimal Glycemic Management. ADA Clinical Compendia, 2026(1), 1–48. Published August 17, 2026. DOI: 10.2337/db20261.

McCoy, R. G., Aleppo, G., Neumiller, J. J., Pilla, S. J., & Riddell, M. C. (2026). Chapter 4. Preventing Hypoglycemia and Mitigating Its Risks. In A Practical Guide to Hypoglycemia: New Approaches to Overcoming a Persistent Barrier to Optimal Glycemic Management. ADA Clinical Compendia, 2026(1), 16–28. DOI: 10.2337/db20261-16.

Munshi, M. N., Florez, H., Huang, E. S., et al. (2016). Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association. Diabetes Care, 39(2), 308–318. DOI: 10.2337/dc15-2512.

Ministry of Health of Viet Nam. (2020). Decision No. 5481/QD-BYT Promulgating the Guidelines for Diagnosis and Treatment of Type 2 Diabetes. Issued December 30, 2020.

Ministry of Health of Viet Nam. (2021). Decision No. 1353/QD-BYT Amending and Supplementing Certain Provisions of the Guidelines for Diagnosis and Treatment of Type 2 Diabetes Issued Under Decision No. 5481/QD-BYT. Issued February 23, 2021.

Ministry of Health of Viet Nam. (2026). Decision No. 1976/QD-BYT Promulgating Professional Guidance on Care for Older Persons at Home and in the Community. Issued July 1, 2026.

National Assembly of Viet Nam. (2023). Law on Medical Examination and Treatment No. 15/2023/QH15, as amended. Effective January 1, 2024.

Office of the National Assembly of Viet Nam. (2026). Consolidated Document No. 26/VBHN-VPQH — Law on Medical Examination and Treatment. Issued February 26, 2026.

National Assembly of Viet Nam. (2009). Law on Older Persons No. 39/2009/QH12, as amended.

National Assembly of Viet Nam. (2025). Law on Personal Data Protection No. 91/2025/QH15. Effective January 1, 2026.

Government of Viet Nam. (2025). Decree No. 356/2025/ND-CP Detailing Certain Articles and Measures for Implementation of the Law on Personal Data Protection. Effective January 1, 2026.

International Organization for Standardization. (2026). ISO 25557:2026 — Ageing Societies — Care Quality for Older Persons at Home and in Care Facilities. Published March 2026.

About Healthy Longevity Vietnam

Healthy Longevity Vietnam (HLVN) is an independent initiative focused on advancing quality, safety, and implementation in age-friendly, integrated, and long-term care for older people in Viet Nam. Through evidence-informed approaches, quality improvement, measurement, and collaboration, HLVN supports healthcare and care organizations in developing safer, more coordinated, and person-centered care across settings.

Disclaimer

This article is intended for general educational, quality improvement, patient safety awareness, and organizational development purposes. It does not constitute individualized medical or legal advice, a diabetes treatment or medication-adjustment protocol, a hypoglycemia emergency treatment algorithm, or a mandatory accreditation or certification standard for healthcare and long-term care organizations in Viet Nam.

The clinical information presented reflects the referenced professional guidance and regulatory context reviewed as of November 4, 2026. It should not be used as a substitute for assessment, diagnosis, treatment, or individualized instructions provided by appropriately qualified healthcare professionals.

Glucose thresholds and hypoglycemia classifications are included for clinical education and risk awareness. They do not independently authorize non-clinical care workers to diagnose hypoglycemia, interpret findings for treatment decisions, prescribe medications, modify doses, or undertake regulated medical procedures.

Clinical decisions concerning diabetes treatment, glucose targets, insulin and other glucose-lowering medications, glucose monitoring, hypoglycemia treatment, emergency medication, and follow-up assessment must take place within appropriate professional arrangements and comply with applicable Vietnamese law.

People with diabetes may perform lawful self-monitoring and follow individualized clinical instructions. Assistance provided by family members, care workers, or other supporters must be appropriate to the person's circumstances, the agreed care plan, their competence, and the applicable legal and organizational requirements.

Suspected severe hypoglycemia, impaired consciousness, seizures, inability to swallow safely, or other serious deterioration require urgent medical assistance. Food or drink must not be given by mouth to a person who cannot swallow safely. Appropriate first aid should not be unnecessarily delayed, and emergency medications must be used within suitable clinical, professional, and legal arrangements.

Caregivers and care organizations should not adopt universal instructions to stop, withhold, or change insulin or other glucose-lowering medications when meals are missed. Medication-related decisions must follow individualized clinical instructions and appropriate professional advice. In particular, inappropriate interruption of insulin treatment in people with type 1 diabetes may cause serious harm.

Residential and home-based care organizations must distinguish everyday assistance, meal support, observation, communication, and care coordination from regulated clinical responsibilities. The scope of permitted activities depends on the applicable law, the provider's legal status and authorized services, and the qualifications and competence of the people involved.

The ADA's Standards of Care in Diabetes—2026 and other international clinical publications are provided as professional references. Their recommendations do not automatically create legal obligations, confer professional authority, or establish mandatory clinical protocols for organizations operating in Viet Nam.

Ministry of Health decisions and professional guidance must be interpreted according to their defined scope, applicable amendments, and current professional requirements. The references to Vietnamese legislation in this article do not constitute a comprehensive legal compliance assessment for any particular organization.

Personal health information, including glucose-monitoring records, medication instructions, and details of clinical events, must be handled in accordance with applicable Vietnamese healthcare confidentiality, privacy, personal data protection, and record-management requirements.

ISO 25557:2026 provides broader principles and requirements concerning care quality, safety, and organizational responsibility. It does not replace clinical diabetes guidance, establish individual glucose targets, or authorize medical treatment.

Healthcare and long-term care organizations should develop locally appropriate arrangements with input from qualified professionals in diabetes care, geriatric medicine, nursing, nutrition, patient safety, quality management, and law where relevant. Organizations should seek professional or regulatory clarification when their responsibilities or permitted activities are uncertain.

Information and regulatory context reviewed as of November 4, 2026.